Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $14.9652W HIGH $31.00
Volume
4.09 M
Value Traded
46.05 M
Short % Float
17.81%
-2.81%Week
+4.42%1 Month
-6.89%3 Month
-1.09%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
3.04 B
EPS (TTM)
0.06
P/E Ratio
392.81
Ent. Value
2.75 B
Total Shares
123.61 M
Float Shares
102.18 M
Insiders
17.33%
Institutions
101.19%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
WRBY Catalyst Timeline
Dated clinical, regulatory and corporate events for Warby Parker Inc.
Catalyst Timeline
Dated clinical, regulatory & corporate events for Warby Parker Inc.
1Total events
0Upcoming
0Tier-1 (high impact)
2026 to 2026Coverage
Event history 1
Past FDA Catalysts and PDUFA Decisions
How WRBY actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Warby Parker Inc. is a medical device company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every WRBY program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Blumenthal Neil HarrisDirector, Officer (Co-Chief Executive Officer) | Sell | -100,000 36,020 held | $27.69 | 10/01/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in WRBY
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in WRBY for Q2 2026. | ||||
WRBY Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-16 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How WRBY ranks across every disease it competes in
Competitive Position is a premium feature
See how WRBY ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialWRBY News
-WRBY
Oct 15, 2026▼ -1.3%today
Warby Parker to Announce Third Quarter 2026 Financial Results on November 5, 2026
Warby Parker Inc. will announce its financial results for the third quarter of 2026 on November 5, 2026. The results will be released before market open, followed by a live conference call at 8:00 a.m. Eastern Time. This event highlights the company's commitment to transparency and investor engagement.
Read more →-WRBY
Sep 8, 2026Warby Parker Announces Participation in the Goldman Sachs 33rd Annual Global Retailing Conference
Warby Parker Inc. has announced its participation in the Goldman Sachs 33rd Annual Global Retailing Conference, scheduled for September 15, 2026. The presentation will take place at 11:30 a.m. Eastern Time and will be available via live webcast. An online archive of the presentation will be accessible for 90 days post-event.
Read more →-WRBY
Aug 6, 2026▼ -7.9%on this news
Warby Parker Announces Second Quarter 2026 Results
Warby Parker Inc. reported its financial results for the second quarter of 2026, showcasing a revenue growth of 9.8%. The company also saw a 4.1% increase in active customers, reaching 2.71 million. Additionally, the average revenue per customer rose by 6.6%, contributing to a net income of $4.6 million and an adjusted EBITDA of $32.9 million.
Read more →-WRBY
Jul 16, 2026Warby Parker to Announce Second Quarter 2026 Financial Results on August 6, 2026
Warby Parker Inc. will release its second quarter financial results for 2026 on August 6, 2026. The announcement includes a live conference call at 8:00 a.m. Eastern Time to discuss the results and business outlook. This reflects the company's commitment to transparency and investor engagement.
Read more →-WRBY
May 28, 2026Warby Parker Announces Participation in Upcoming 2026 Baird Global Consumer, Technology & Services Conference
Warby Parker has announced its participation in the upcoming 2026 Baird Global Consumer, Technology & Services Conference. The announcement highlights the company's ongoing engagement with investors and stakeholders in the consumer and technology sectors. Further details about the event and the company's agenda have not been disclosed.
Read more →-WRBY
May 19, 2026▼ -11%on this news
Warby Parker Unveils First Intelligent Eyewear Design
Warby Parker has launched its first intelligent eyewear design, emphasizing privacy protection. This new product aims to integrate technology into everyday eyewear while ensuring user data remains secure. The innovative design is expected to enhance the overall user experience, marking a significant step for the brand in the tech eyewear market.
Read more →-WRBY
May 7, 2026▲ +23.5%on this news· ran to +34% by day 1
Warby Parker Announces First Quarter 2026 Results
Warby Parker Inc. reported strong financial results for Q1 2026, with an 8.3% revenue increase to $242.4 million and a net income of $3.2 million. Active customers grew by 4.8%, reaching 2.69 million, while the company expanded its store count to 337. Despite a decrease in gross margin and a slight dip in net income, the outlook for 2026 remains optimistic with plans for 50 new store openings and the launch of intelligent eyewear.
Read more →-WRBY
Apr 28, 2026Warby Parker Launches Warby Parker Sport, Expanding into the Performance Eyewear Category
Warby Parker has introduced Warby Parker Sport, a new line of performance eyewear designed for both everyday use and active lifestyles. The collection features five frame styles made from lightweight materials and incorporates advanced lens technology for improved vision. The launch reflects the brand's commitment to inclusivity for prescription wearers and its growing presence in sports culture. Warby Parker Sport is available online and in retail locations, with a portion of sales supporting eyewear donations.
Read more →-WRBY
Apr 16, 2026Warby Parker to Announce First Quarter 2026 Financial Results on May 7, 2026
Warby Parker is set to announce its financial results for the first quarter of 2026 on May 7, 2026. This announcement is part of the company's regular financial reporting schedule. Investors and analysts will be keenly awaiting the details of the results to assess the company's performance.
Read more →-WRBY
Feb 9, 2026▼ -5.4%on this news· ran to -16% by day 3
Warby Parker Appoints Adrian Mitchell as Chief Financial Officer
Warby Parker has appointed Adrian Mitchell as the new Chief Financial Officer, effective February 10, 2026. With over 25 years of experience in significant consumer brands, Mitchell aims to enhance the company's growth strategies and leadership. His appointment comes during an ambitious phase for Warby Parker, which includes the launch of AI glasses and a commitment to improving vision accessibility. Mitchell previously led transformative initiatives at Macy's and Crate & Barrel and holds an MBA from Harvard Business School.
Read more →-WRBY
May 20, 2025▲ +15.6%on this news
Warby Parker Partners with Google To Develop Intelligent Eyewear Glasses Will Be Designed for All-Day Wear
Warby Parker has announced a partnership with Google to develop AI-powered smart glasses designed for all-day wear. The collaboration, marking Google's first eyewear partnership for Android XR, includes a financial commitment of up to $150 million to support product development. Warby Parker's focus on innovative eyewear design will combine with Google's advanced technology to venture into a new category of connected computing. The first line of intelligent eyewear is slated for launch after 2025, indicating a long-term project ahead.
Read more →-WRBY
Sep 28, 2021Warby Parker Announces Update Regarding Conversion of Shares of Class B Common Stock to Shares of Class A Common Stock
Warby Parker Announces Update Regarding Conversion of Shares of Class B Common Stock to Shares of Class A Common Stock NEW YORK, September 28, 2021. Warby Parker Inc. (the "Company"), a founder-led direct-to-consumer eyewear brand, today announced that, as of September 28, 2021,
Read more →-WRBY
Sep 21, 2021Warby Parker Releases Financial Guidance for the Third Quarter and Fiscal Year 2021 and Fiscal Year 2022
Warby Parker Releases Financial Guidance for the Third Quarter and Fiscal Year 2021 and Fiscal Year 2022 NEW YORK, September 21, 2021. Warby Parker Inc. (the "Company"), a founder-led direct-to-consumer eyewear brand, today issued guidance for the third quarter ending September
Read more →About Warby Parker Inc.
Headquarters233 SPRING STREET, NEW YORK, NY, 10013
BIOPHARMAWATCH ELITE PLUS
Trade the next WRBY catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime